CN103012530B - 化合物endecaphyllacins B的制备方法及其在制备抗肿瘤药物中的应用 - Google Patents
化合物endecaphyllacins B的制备方法及其在制备抗肿瘤药物中的应用 Download PDFInfo
- Publication number
- CN103012530B CN103012530B CN201210576060.9A CN201210576060A CN103012530B CN 103012530 B CN103012530 B CN 103012530B CN 201210576060 A CN201210576060 A CN 201210576060A CN 103012530 B CN103012530 B CN 103012530B
- Authority
- CN
- China
- Prior art keywords
- verbindung
- antitumor drug
- preparing
- present
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002246 antineoplastic agent Substances 0.000 title claims abstract description 15
- 229940041181 antineoplastic drug Drugs 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title abstract description 7
- 201000011510 cancer Diseases 0.000 claims description 9
- 206010028980 Neoplasm Diseases 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 7
- 206010006187 Breast cancer Diseases 0.000 claims description 4
- 208000026310 Breast neoplasm Diseases 0.000 claims description 4
- 201000007270 liver cancer Diseases 0.000 claims description 4
- 208000014018 liver neoplasm Diseases 0.000 claims description 4
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims description 3
- 201000005202 lung cancer Diseases 0.000 claims description 3
- 208000020816 lung neoplasm Diseases 0.000 claims description 3
- 230000000259 anti-tumor effect Effects 0.000 abstract description 9
- 150000001875 compounds Chemical class 0.000 abstract description 8
- 241000196324 Embryophyta Species 0.000 abstract description 6
- 238000012827 research and development Methods 0.000 abstract description 3
- 238000000926 separation method Methods 0.000 abstract description 2
- 241000984061 Aquilaria Species 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 8
- SRCZQMGIVIYBBJ-UHFFFAOYSA-N ethoxyethane;ethyl acetate Chemical compound CCOCC.CCOC(C)=O SRCZQMGIVIYBBJ-UHFFFAOYSA-N 0.000 description 7
- 239000003208 petroleum Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 229940125904 compound 1 Drugs 0.000 description 6
- 210000004881 tumor cell Anatomy 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- 239000003480 eluent Substances 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229910052697 platinum Inorganic materials 0.000 description 3
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 3
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 2
- 239000012980 RPMI-1640 medium Substances 0.000 description 2
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 239000007900 aqueous suspension Substances 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000009509 drug development Methods 0.000 description 2
- 238000001641 gel filtration chromatography Methods 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- XELZGAJCZANUQH-UHFFFAOYSA-N methyl 1-acetylthieno[3,2-c]pyrazole-5-carboxylate Chemical compound CC(=O)N1N=CC2=C1C=C(C(=O)OC)S2 XELZGAJCZANUQH-UHFFFAOYSA-N 0.000 description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N methyl alcohol Substances OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 2
- 239000002547 new drug Substances 0.000 description 2
- 238000012746 preparative thin layer chromatography Methods 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- 241001533085 Aquilaria sinensis Species 0.000 description 1
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 208000029462 Immunodeficiency disease Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
- 229960004316 cisplatin Drugs 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000003810 ethyl acetate extraction Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000007813 immunodeficiency Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 208000002154 non-small cell lung carcinoma Diseases 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 229960001814 trypan blue Drugs 0.000 description 1
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (2)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210576060.9A CN103012530B (zh) | 2012-12-26 | 2012-12-26 | 化合物endecaphyllacins B的制备方法及其在制备抗肿瘤药物中的应用 |
CN201410767701.8A CN104497087B (zh) | 2012-12-26 | 2012-12-26 | 一种化合物endecaphyllacins B的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210576060.9A CN103012530B (zh) | 2012-12-26 | 2012-12-26 | 化合物endecaphyllacins B的制备方法及其在制备抗肿瘤药物中的应用 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410767701.8A Division CN104497087B (zh) | 2012-12-26 | 2012-12-26 | 一种化合物endecaphyllacins B的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103012530A CN103012530A (zh) | 2013-04-03 |
CN103012530B true CN103012530B (zh) | 2016-02-24 |
Family
ID=47961679
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210576060.9A Active CN103012530B (zh) | 2012-12-26 | 2012-12-26 | 化合物endecaphyllacins B的制备方法及其在制备抗肿瘤药物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103012530B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105601607B (zh) * | 2016-03-10 | 2018-01-05 | 广东省微生物研究所 | 化合物acaromycin A及其制备方法和在制备抗肿瘤药物中的应用 |
CN109045154A (zh) * | 2018-09-21 | 2018-12-21 | 珠海霍普金斯医药研究院股份有限公司 | 一种具有抗肿瘤作用的野生白木香叶提取物及其在制备功能饮料或保健食品中的应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101411789A (zh) * | 2008-12-05 | 2009-04-22 | 中国热带农业科学院热带生物技术研究所 | 白木香果实及其提取物在制备抗肿瘤药物中的新用途 |
-
2012
- 2012-12-26 CN CN201210576060.9A patent/CN103012530B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101411789A (zh) * | 2008-12-05 | 2009-04-22 | 中国热带农业科学院热带生物技术研究所 | 白木香果实及其提取物在制备抗肿瘤药物中的新用途 |
Non-Patent Citations (2)
Title |
---|
Octanorcucurbitane and Cucurbitane Triterpenoids from the Tubers of Hemsleya endecaphylla with HIV-1 Inhibitory Activity.;Chen, Jian-Chao等;《Journal of Natural Products》;20081231;第71卷(第1期);第153-155页 * |
白木香果皮挥发性成分及抗肿瘤活性的研究;徐维娜等;《中药材》;20101130;第33卷(第11期);第1376-1740页 * |
Also Published As
Publication number | Publication date |
---|---|
CN103012530A (zh) | 2013-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhang et al. | Cucurbitane-type glycosides from the fruits of Momordica charantia and their hypoglycaemic and cytotoxic activities | |
CN101824067A (zh) | 玉蕊醇型三萜皂苷类化合物、制备方法及其应用 | |
CN108003214A (zh) | 一种从土贝母中提取的皂苷化合物及其方法和应用 | |
CN102247393B (zh) | 一种齐墩果酸皂苷类成分的制备方法及其用途 | |
CN103012530B (zh) | 化合物endecaphyllacins B的制备方法及其在制备抗肿瘤药物中的应用 | |
CN104497087B (zh) | 一种化合物endecaphyllacins B的制备方法 | |
CN103113433B (zh) | 一种从巧玲花中提取橄榄苦苷的方法 | |
CN103088083A (zh) | 抗炎、抗肿瘤活性倍半萜内酯类化合物的制备方法 | |
CN106727598B (zh) | 阔叶丰花草三萜化合物的制备方法及其在制备糖苷酶抑制剂药物中的应用 | |
CN105061545B (zh) | 文冠果中三萜皂苷类化合物及其制备方法和应用 | |
Van Khang et al. | Cardenolides from the bark of Calotropis gigantea | |
CN104523792A (zh) | 一种富含强心苷的马利筋乳汁提取物及其制备方法与应用 | |
CN109456191A (zh) | 化合物cerrenin D及其制备方法和在制备抗肿瘤药物中的应用 | |
CN107880084A (zh) | 从凌霄属植物花中提取制备高纯度毛蕊花糖苷的方法 | |
CN104926773A (zh) | 皂角刺中黄烷酮骨架类化合物的提取方法及化合物的应用 | |
CN102911236A (zh) | 大花金鸡菊叶中β-谷甾醇的提取方法及其新用途 | |
CN104274429B (zh) | 环阿尔廷型三萜化合物在制备抗肺癌药物中的应用 | |
CN106554340A (zh) | 一种紫藤瘤中单体化合物的用途及其分离纯化方法 | |
Kakarla et al. | Morphological and chemoprofile (liquid chromatography-mass spectroscopy and gas chromatography-mass spectroscopy) comparisons of Cyperus scariosus R. Br and Cyperus rotundus L. | |
CN102168119B (zh) | 一种制备diaporthein B的方法及diaporthein B在制备抗肿瘤药物中的应用 | |
CN104490986B (zh) | 一种甘遂活性组分及其制备方法与应用 | |
Zaman et al. | Isolation of Two New Cheilanthane-Type Tricarbocyclic Sesterterpenoids from Leaves of Caesalpinia crista Linn.: A Traditionally Used Antimalarial Plant of Assam, India | |
Aiyelaagbe et al. | Chemical constituents from Alafia barteri Oliv. Leaves with cytotoxic activity | |
CN105330713B (zh) | 3β‑乙酰氧基人参皂苷F1及其提取方法和药物用途 | |
CN103980196A (zh) | 一种海南暗罗根提取物的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 510070 No. 100 martyrs Middle Road, Guangdong, Guangzhou Patentee after: GUANGDONG INSTITUTE OF MICROBIOLOGY (GUANGDONG DETECTION CENTER OF MICROBIOLOGY) Address before: 510070 No. 100 martyrs Middle Road, Guangdong, Guangzhou Patentee before: Guangdong Institute of Microbiology |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: No. 56, courtyard, No. 100, Xianlie Middle Road, Guangzhou, Guangdong 510070 Patentee after: Institute of Microbiology, Guangdong Academy of Sciences Address before: 510070 No. 100 martyrs Middle Road, Guangdong, Guangzhou Patentee before: GUANGDONG INSTITUTE OF MICROBIOLOGY (GUANGDONG DETECTION CENTER OF MICROBIOLOGY) |